Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | -0.1x - -0.1x | -0.1x |
| Historical Pb Multiple | -0.4x - -0.1x | -0.4x |
| Fair Value | $0.021 - $0.023 | $0.022 |
| Upside | 24.1% - 37.2% | 30.6% |
| Benchmarks | - | Full Ticker |
| FitLife Brands, Inc. | - | NasdaqCM:FTLF |
| Natural Alternatives International, Inc. | - | NasdaqGM:NAII |
| BioRegenx, Inc. | - | OTCPK:BRGX |
| Safety Shot, Inc. | - | NasdaqCM:SHOT |
| BellRing Brands, Inc. | - | NYSE:BRBR |
| BioAdaptives, Inc. | - | OTCPK:BDPT |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| FTLF | NAII | BRGX | SHOT | BRBR | BDPT | |||
| NasdaqCM:FTLF | NasdaqGM:NAII | OTCPK:BRGX | NasdaqCM:SHOT | NYSE:BRBR | OTCPK:BDPT | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 27.8% | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | 18.4% | NM- | NM- | NM- | 107.5% | NM- | ||
| Latest Twelve Months | 21.1% | -149.0% | -209.2% | -38.2% | 46.7% | -7.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 18.9% | 1.0% | -298.3% | -4325.8% | 10.0% | -10427.4% | ||
| Prior Fiscal Year | 10.0% | 1.6% | -105.5% | -7313.1% | 9.9% | -2494.2% | ||
| Latest Fiscal Year | 13.9% | -6.3% | -985.2% | -7223.3% | 12.3% | -7097.3% | ||
| Latest Twelve Months | 13.8% | -6.6% | -874.7% | -7039.0% | 12.8% | -116976.3% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 44.2% | 3.3% | -108.9% | -602.7% | 7.6% | NA | ||
| Prior Fiscal Year | 21.9% | 2.8% | NM | -237.5% | NM | NM | ||
| Latest Twelve Months | 25.9% | -10.2% | -237.1% | -1449.0% | NM | NM | ||
| Next Fiscal Year | 23.8% | #NUM! | #NUM! | #NUM! | -132.2% | #NUM! | ||
| Two Fiscal Years Forward | 22.6% | -9.2% | 154.7% | 193.9% | -148.5% | 0.0% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 1.9x | 0.2x | 6.8x | 187.7x | 3.2x | 248.0x | ||
| Price / LTM EPS | 13.7x | -2.7x | -0.8x | -2.7x | 24.7x | -0.2x | ||
| Price / Book | 3.1x | 0.3x | -4.4x | -198.3x | -27.4x | -0.1x | ||
| Price / Fwd Book | 2.6x | 0.3x | -4.6x | -49.5x | -30.5x | -0.1x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | -198.3x | -4.4x | 3.1x | |||||
| Historical P/B Ratio | -0.4x | -0.4x | -0.1x | |||||
| Selected P/B Multiple | -0.1x | -0.1x | -0.1x | |||||
| (x) Book Value | (2) | (2) | (2) | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | FTLF | NAII | BRGX | SHOT | BRBR | BDPT | |
| Value of Common Equity | 121 | 22 | 16 | 108 | 6,952 | 0 | |
| (/) Shares Outstanding | 9.4 | 6.2 | 960.3 | 144.0 | 127.0 | 9.0 | |
| Implied Stock Price | 12.90 | 3.62 | 0.02 | 0.75 | 54.74 | 0.02 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 12.90 | 3.62 | 0.02 | 0.75 | 54.74 | 0.02 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |